A Phase 3B Multi-Center, Open Label, Single Arm, 48-Week Study, Evalua
Research payments
$1,546,764
Through program year 2021, $1,546,764 in research payments was reported against A Phase 3B Multi-Center, Open Label, Single Arm, 48-Week Study, Evalua, across 247 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $311,663 | 62 |
| 2020 | Research | $848,651 | 126 |
| 2019 | Research | $386,451 | 59 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jay Gladstein Los Angeles, CA Named on 23 payments
- James Sims Bellaire, TX Named on 16 payments
- Anson Wurapa Decatur, GA Named on 14 payments
- Tulika Singh Palm Springs, CA Named on 12 payments
- Roberto Ortiz Orlando, FL Named on 11 payments
- Debbie Hagins Savannah, GA Named on 11 payments
- William Henry Minneapolis, MN Named on 11 payments
- David Parks Saint Louis, MO Named on 9 payments
- Frederick Cruickshank Huntersville, NC Named on 9 payments
- Dushyantha Jayaweera Miami, FL Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.